Search research articles
Contact Us
Filters
Showing results (61-70 of 224) with videos related to
Page
of 23
Sort By:
Frontiers in Oncology
|
May 6, 2022
The Landscape of Immunotherapy Resistance in NSCLC
Daniele Frisone, Alex Friedlaender, Alfredo Addeo, et al.
World Journal of Clinical Oncology
|
May 7, 2021
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
Mathieu Chevallier, Maxime Borgeaud, Alfredo Addeo, et al.
Revue Medicale Suisse
|
May 15, 2025
Alfredo Addeo, Fernanda Herrera, Pelagia Tsoutsou, et al.
ESMO Open
|
November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer
Nuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse
|
May 18, 2026
Fernanda Herrera, Pelagia Tsoutsou, Alfredo Addeo, et al.
Current Oncology Reports
|
November 27, 2019
Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era
Alex Friedlaender, Giuseppe Luigi Banna, Lucio Buffoni, et al.
ESMO Open
|
May 16, 2020
Reply to Authors
Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Lung Cancer Management
|
December 7, 2019
Identifying successful biomarkers for patients with non-small-cell lung cancer
Alex Friedlaender, Joshua Bauml, Giuseppe Luigi Banna, et al.
ESMO Open
|
April 5, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: <i>primum non nocere</i>
Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point
Alfredo Addeo, Francesca Caparrotti, Cristina Picardi, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 224) with videos related to
Sort By:
Page
of 23
Frontiers in Oncology
|
May 6, 2022
The Landscape of Immunotherapy Resistance in NSCLC
Daniele Frisone, Alex Friedlaender, Alfredo Addeo, et al.
World Journal of Clinical Oncology
|
May 7, 2021
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
Mathieu Chevallier, Maxime Borgeaud, Alfredo Addeo, et al.
Revue Medicale Suisse
|
May 15, 2025
Alfredo Addeo, Fernanda Herrera, Pelagia Tsoutsou, et al.
ESMO Open
|
November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer
Nuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse
|
May 18, 2026
Fernanda Herrera, Pelagia Tsoutsou, Alfredo Addeo, et al.
Current Oncology Reports
|
November 27, 2019
Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era
Alex Friedlaender, Giuseppe Luigi Banna, Lucio Buffoni, et al.
ESMO Open
|
May 16, 2020
Reply to Authors
Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Lung Cancer Management
|
December 7, 2019
Identifying successful biomarkers for patients with non-small-cell lung cancer
Alex Friedlaender, Joshua Bauml, Giuseppe Luigi Banna, et al.
ESMO Open
|
April 5, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: <i>primum non nocere</i>
Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point
Alfredo Addeo, Francesca Caparrotti, Cristina Picardi, et al.
Page
of 23